Ensign Peak Advisors Inc trimmed its stake in shares of Booz Allen Hamilton Holding Co. (NYSE:BAH – Free Report) by 1.2% during the second quarter, Holdings Channel reports. The firm owned 59,878 shares of the business services provider’s stock after selling 755 shares during the period. Ensign Peak Advisors Inc’s holdings in Booz Allen Hamilton were worth $9,215,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of BAH. Price T Rowe Associates Inc. MD raised its stake in Booz Allen Hamilton by 2.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 10,406,880 shares of the business services provider’s stock worth $1,544,798,000 after acquiring an additional 222,884 shares in the last quarter. WCM Investment Management LLC lifted its holdings in Booz Allen Hamilton by 0.5% during the 1st quarter. WCM Investment Management LLC now owns 4,252,168 shares of the business services provider’s stock valued at $631,192,000 after purchasing an additional 22,708 shares during the last quarter. AGF Management Ltd. boosted its position in Booz Allen Hamilton by 63.4% in the second quarter. AGF Management Ltd. now owns 1,750,610 shares of the business services provider’s stock valued at $269,419,000 after buying an additional 679,280 shares in the last quarter. American Century Companies Inc. grew its stake in Booz Allen Hamilton by 6.1% during the second quarter. American Century Companies Inc. now owns 1,672,961 shares of the business services provider’s stock worth $257,469,000 after buying an additional 96,553 shares during the last quarter. Finally, Axiom Investors LLC DE increased its holdings in shares of Booz Allen Hamilton by 9.4% during the fourth quarter. Axiom Investors LLC DE now owns 1,185,362 shares of the business services provider’s stock worth $151,620,000 after buying an additional 102,062 shares in the last quarter. 91.82% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms recently commented on BAH. Truist Financial increased their price target on Booz Allen Hamilton from $140.00 to $165.00 and gave the stock a “hold” rating in a research report on Thursday, September 5th. JPMorgan Chase & Co. increased their target price on Booz Allen Hamilton from $136.00 to $154.00 and gave the stock a “neutral” rating in a report on Wednesday, July 10th. Wells Fargo & Company raised Booz Allen Hamilton from an “equal weight” rating to an “overweight” rating and cut their price target for the company from $168.00 to $165.00 in a report on Monday, July 29th. TD Cowen decreased their price objective on shares of Booz Allen Hamilton from $185.00 to $165.00 and set a “buy” rating on the stock in a report on Monday, July 29th. Finally, Jefferies Financial Group upped their target price on shares of Booz Allen Hamilton from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Wednesday, May 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Booz Allen Hamilton currently has an average rating of “Moderate Buy” and an average price target of $159.33.
Insiders Place Their Bets
In related news, Director Melody C. Barnes sold 1,041 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $143.31, for a total transaction of $149,185.71. Following the completion of the sale, the director now directly owns 18,123 shares of the company’s stock, valued at approximately $2,597,207.13. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.59% of the company’s stock.
Booz Allen Hamilton Price Performance
Shares of BAH stock opened at $159.74 on Wednesday. The firm’s 50 day moving average price is $152.18 and its two-hundred day moving average price is $150.87. The stock has a market cap of $20.66 billion, a PE ratio of 34.73, a PEG ratio of 2.19 and a beta of 0.59. Booz Allen Hamilton Holding Co. has a 52-week low of $106.90 and a 52-week high of $164.43. The company has a debt-to-equity ratio of 3.07, a quick ratio of 1.55 and a current ratio of 1.55.
Booz Allen Hamilton (NYSE:BAH – Get Free Report) last announced its quarterly earnings data on Friday, July 26th. The business services provider reported $1.38 EPS for the quarter, missing analysts’ consensus estimates of $1.52 by ($0.14). Booz Allen Hamilton had a return on equity of 65.80% and a net margin of 5.57%. The company had revenue of $2.94 billion for the quarter, compared to analyst estimates of $2.92 billion. As a group, analysts forecast that Booz Allen Hamilton Holding Co. will post 5.96 EPS for the current year.
Booz Allen Hamilton Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were given a $0.51 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Wednesday, August 14th. Booz Allen Hamilton’s dividend payout ratio is currently 44.35%.
Booz Allen Hamilton Profile
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital solutions, mission operations, and cyber services to governments, corporations, and not-for-profit organizations in the United States and internationally. It focuses on artificial intelligence services comprising of machine learning, predictive modeling, automation and decision analytics, and quantum computing.
Featured Articles
- Five stocks we like better than Booz Allen Hamilton
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Buy Cheap Stocks Step by Step
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding BAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Booz Allen Hamilton Holding Co. (NYSE:BAH – Free Report).
Receive News & Ratings for Booz Allen Hamilton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booz Allen Hamilton and related companies with MarketBeat.com's FREE daily email newsletter.